First-trimester prenatal diagnosis in haemophilia A and B families--10 years experience from a centre in India.
During the last 10 years (1995-2005) we have offered diagnosis in 438 families out of 502 families referred, by chorionic villus sampling procedure between 10 and 12 weeks of pregnancy in severe haemophilia A and B families. Sixty four families could not be offered a diagnosis in the first trimester either due to non-informativeness with the available techniques or due to the absence of affected members in the family and were subsequently offered diagnosis in the second trimester by direct analysis of factor VIII/IX clotting activity and antigen in the fetal blood samples. For first-trimester diagnosis in the chorionic villus samples, we have used both direct and indirect methods, that is, intron 22 and 1 inversions in the factor VIII gene, a multiplex PCR for the detection of gross deletions in the factor IX gene and RFLP analysis using a battery of markers within and outside the factor VIII/IX gene. The informativeness of all these techniques was found to be 92.21% in case of haemophilia A and 83.91% in case of haemophilia B. We followed up 122 children out of 326 (diagnosed unaffected prenatally) after birth and the diagnosis was adequately reconfirmed by both factor assays and by DNA analysis. Only one case of misdiagnosis was detected so far (0.22%), where the diagnosis was based only on the extragenic marker of the factor VIII gene.
Shetty
Shrimati
S
Institute of Immunohaematology (ICMR), Department of Haematology, KEM Hospital, Parel, Mumbai 400 012, India.
Ghosh
Kanjaksha
K
Jijina
Farah
F
D015193:Chorionic Villi Sampling; D005164:Factor IX / Q000235:genetics*; D005169:Factor VIII / Q000235:genetics*; D005260:Female; D005315:Fetal Diseases / Q000175:diagnosis; D005819:Genetic Markers; D006467:Hemophilia A / Q000175:diagnosis*; D002836:Hemophilia B / Q000175:diagnosis*; D006801:Humans; D007194:India; D007438:Introns; D008297:Male; D011247:Pregnancy; D011296:Prenatal Diagnosis
D005819:Genetic Markers; D005169:Factor VIII; D005164:Factor IX